<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="jointly assess MAYV epidemiology and the extent of cross-reactivity with" exact="CHIKV" post="from serological data collected throughout French Guiana (N = 2697). We"/>
 <result pre="of this emerging pathogen. However, following the widescale circulation of" exact="CHIKV" post="in the Americas since 2013, the evaluation of MAYV"/>
 <result pre="of MAYV infection is greatly complicated by serological cross-reactivity where" exact="CHIKV" post="infected individuals may experience a rise in MAYV antibody"/>
 <result pre="that by jointly analyzing serological results for both MAYV and" exact="CHIKV" post="alongside data on the age and location of participants,"/>
 <result pre="extent of cross-reactivity. We apply our approach to MAYV and" exact="CHIKV" post="in French Guiana, a territory that has seen a"/>
 <result pre="CHIKV in French Guiana, a territory that has seen a" exact="CHIKV" post="epidemic between February 2014 and October 201513–15, as well"/>
 <result pre="serum sample, we measured antibody responses to both MAYV and" exact="CHIKV" post="using a multiplexed microsphere-based IgG immunoassay (MIA) that returned"/>
 <result pre="each pathogen19 (see Methods section). Results Serology of MAYV and" exact="CHIKV" post="We find that almost all participants with a MAYV"/>
 <result pre="with a MAYV RFI signal also exhibit a signal for" exact="CHIKV" post="(Fig. 1a). In the absence of a good understanding"/>
 <result pre="cross-reactivity with CHIKV, MAYV RFI should be roughly proportional to" exact="CHIKV" post="RFI in each region of French Guiana. However, we"/>
 <result pre="the average MAYV RFI is much lower than the average" exact="CHIKV" post="RFI in Cayenne, it is higher in High Oyapock"/>
 <result pre="at which a susceptible individual gets infected) for MAYV and" exact="CHIKV" post="modulated by pathogen-specific socio-demographic factors, and how RFIs change"/>
 <result pre="Tables 2 and 3). Fig. 1 Serology of MAYV and" exact="CHIKV" post="in French Guiana. a MAYV and CHIKV relative fluorescence"/>
 <result pre="of MAYV and CHIKV in French Guiana. a MAYV and" exact="CHIKV" post="relative fluorescence intensity (RFI) for the 2697 individuals included"/>
 <result pre="groups is shown for each region for MAYV (purple) and" exact="CHIKV" post="(orange). Sample sizes for each age class are given"/>
 <result pre="with MAYV and by 0.22 (95% CrI: 0.20–0.23) after a" exact="CHIKV" post="infection while CHIKV RFI increases by 1.05 (95% CrI:"/>
 <result pre="by 0.22 (95% CrI: 0.20–0.23) after a CHIKV infection while" exact="CHIKV" post="RFI increases by 1.05 (95% CrI: 1.01–1.1) after a"/>
 <result pre="MAYV infection and by 3.64 (95% CrI: 3.60–3.67) after a" exact="CHIKV" post="infection (Tab S4). Assessing the history of virus circulation"/>
 <result pre="of the yearly probability of infection by MAYV (purple) and" exact="CHIKV" post="(orange) of an adult male in the different regions"/>
 <result pre="95% credible intervals. b Relative risk of MAYV (purple) and" exact="CHIKV" post="(orange) infection of individuals above 20 years old (relative"/>
 <result pre="find that females are more likely to be infected by" exact="CHIKV" post="than males (relative FOI is 1.2, 95% CrI: 1.0–1.4)"/>
 <result pre="be infected (Fig. 2b). We find an increased risk of" exact="CHIKV" post="infection for individuals that spend more time at home."/>
 <result pre="whether this observation could help explain the increased level of" exact="CHIKV" post="infection among women. In the survey, participants were asked"/>
 <result pre="Spending time at home was also associated with infection by" exact="CHIKV" post="(OR, 95% CrI: 1.84 (1.41–2.40)), but not significantly associated"/>
 <result pre="(0.79–2.14)). These findings are consistent with a previous study on" exact="CHIKV" post="transmission in Bangladesh, which suggested that the increased time"/>
 <result pre="of the assays the probability of infection by MAYV and/or" exact="CHIKV" post="and classifies the result as infected if the estimated"/>
 <result pre="Figs. 3 to 5). Fig. 3 Classification of MAYV and" exact="CHIKV" post="infections. a Graphical representation of the model-based classification that"/>
 <result pre="model-based classification that determines the infection status for MAYV and" exact="CHIKV" post="from the measured MAYV and CHIKV RFIs. For a"/>
 <result pre="status for MAYV and CHIKV from the measured MAYV and" exact="CHIKV" post="RFIs. For a classification with a simple cut-off, MAYV"/>
 <result pre="lie on the right of the dashed purple curve, and" exact="CHIKV" post="positive samples above the orange curve. The boundaries were"/>
 <result pre="plotted considering a probability of MAYV infection of 5% and" exact="CHIKV" post="infection of 20% (see Supplementary Fig. 4 for a"/>
 <result pre="6, Supplementary Tables 9 and 10). This geographical distribution of" exact="CHIKV" post="appears similar to that previously found for Zika virus"/>
 <result pre="distribution of CHIKV appears similar to that previously found for" exact="Zika" post="virus (ZIKV)18. For both ZIKV and CHIKV, risk may"/>
 <result pre="to that previously found for Zika virus (ZIKV)18. For both" exact="ZIKV" post="and CHIKV, risk may be driven by the repartition"/>
 <result pre="remote villages including Antecume Pata, Trois-Sauts and Camopi villages22 where" exact="CHIKV" post="seroprevalence rates varied from 0% to 1.42%. Furthermore, we"/>
 <result pre="to other areas. Fig. 4 Geographic distribution of MAYV and" exact="CHIKV" post="seroprevalence. a Three regions of French Guiana with distinct"/>
 <result pre="are derived using the model estimates. b, MAYV and c," exact="CHIKV" post="seroprevalence estimated using the model-based classification (Maroni, n = 618; Coast,"/>
 <result pre="we inferred infections with a simple optimized cut-off, cross-reactivity with" exact="CHIKV" post="would have led to overestimating the number of historical"/>
 <result pre="future MAYV emergence, it is important to understand how the" exact="CHIKV" post="outbreak affected the susceptibility to MAYV. With our model-based"/>
 <result pre="(MIA) based on recombinant antigens. The recombinant ectodomain of the" exact="CHIKV" post="and MAYV envelope E2 glycoproteins were used for the"/>
 <result pre="using a MagPix instrument (Bio-Rad Laboratories). For each sample, the" exact="CHIKV" post="and MAYV Relative Fluorescence Intensities (RFI) were calculated by"/>
 <result pre="were calculated by dividing the MFI signal measured for the" exact="CHIKV" post="or MAYV microsphere sets by the MFI signal obtained"/>
 <result pre="tissue culture infectious dose 50 (TCID 50) of MAYV or" exact="CHIKV" post="(French Guiana strains). After incubation at 37 °C for 1 h,"/>
 <result pre="37 °C for 6 days for MAYV and 5 days for" exact="CHIKV" post="before lecture of cytopathic effects. The neutralization titer is"/>
 <result pre="standard deviation εM Cross-reactivity is modeled as an increase in" exact="CHIKV" post="log RFI by a factor that is proportional to"/>
 <result pre="multiplicative term. 3. If an individual has been infected by" exact="CHIKV" post="only, we similarly model the increase in CHIKV RFI"/>
 <result pre="infected by CHIKV only, we similarly model the increase in" exact="CHIKV" post="RFI and cross-reactivity by 4 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts}"/>
 <result pre="j ) . The total cumulative strengths of MAYV and" exact="CHIKV" post="infection for individual j are 9 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym}"/>
 <result pre="assumed no spatial difference in the timing of epidemics. The" exact="CHIKV" post="outbreak started in the region of Kourou and then"/>
 <result pre="used a univariate logistic regression model to predict MAYV and/or" exact="CHIKV" post="infections determined by the model with socio-demographic or environmental"/>
 <result pre="variable in the FOI model. Model-based classification of MAYV and" exact="CHIKV" post="infections Conditional on parameter value θ, the probability that"/>
 <result pre="We plotted the histograms of MAYV (Supplementary Fig. 5a) and" exact="CHIKV" post="RFIs (Supplementary Fig. 5b), together with the value of"/>
 <result pre="into account cross-reactivity in the understanding of the epidemiology of" exact="CHIKV" post="and MAYV, we fitted standard serocatalytic models to data,"/>
 <result pre="model-based classification and the simple cutoff is that MAYV and" exact="CHIKV" post="have contrasting risk factors for infection: males (respectively, females)"/>
 <result pre="to MAYV (respectively, CHIKV). Many children and women infected by" exact="CHIKV" post="in the urban areas are tested positive for MAYV"/>
 <result pre="improved the fit for MAYV RFIs, it worsened it for" exact="CHIKV" post="RFIs (Supplementary Fig. 2), and no overall improvement in"/>
 <result pre="of infections for the number of infected by MAYV and/or" exact="CHIKV" post="in the simulation (Supplementary Table 3) were well estimated."/>
 <result pre="of virus circulation models where (i) MAYV is constant and" exact="CHIKV" post="is epidemic, (ii) both MAYV and CHIKV are epidemic,"/>
 <result pre="is constant and CHIKV is epidemic, (ii) both MAYV and" exact="CHIKV" post="are epidemic, (iii) both MAYV and CHIKV are constant,"/>
 <result pre="both MAYV and CHIKV are epidemic, (iii) both MAYV and" exact="CHIKV" post="are constant, (iii) MAYV is epidemic and CHIKV circulation"/>
 <result pre="MAYV and CHIKV are constant, (iii) MAYV is epidemic and" exact="CHIKV" post="circulation is constant. DICs of the different models are"/>
 <result pre="the fit for MAYV RFIs but gave worse results for" exact="CHIKV" post="RFIs. No overall improvement in terms of DIC was"/>
 <result pre="CrI: 1.9–2.18) for males. Similarly females had a slightly higher" exact="CHIKV" post="response of 3.71 (95% CrI: 3.65–3.75) vs. 3.55 (95%"/>
 <result pre="the baseline model) and 192 males and 350 females for" exact="CHIKV" post="(total = 542, which is the same as the baseline model)."/>
 <result pre="https://github.com/nathoze/Mayaro. For each individual: age group (10-year classes), MAYV RFI," exact="CHIKV" post="RFI, region (Maroni, Coast, Interior and High Oyapock), sex,"/>
 <result pre="of an arthropod-borne virus in Brazil?Braz. J. Infect. Dis.20172154054410.1016/j.bjid.2017.06.00228688628 2.HotezPJMurrayKODengue," exact="West Nile" post="virus, chikungunya, Zika-and now MayaroPLoS Negl. Trop. Dis.201711e000546210.1371/journal.pntd.000546228859086 3.MavianCet"/>
 <result pre="emergence of a new arbovirus: implications for the control of" exact="Chikungunya" post="virus in French GuianaPLoS Negl. Trop. Dis.201610e000508110.1371/journal.pntd.000508127802275 16.Llagonne-BaretsMet al.A"/>
 <result pre="identification, and seroprevalenceAm. J. Trop. Med. Hyg.19985945245610.4269/ajtmh.1998.59.4529749643 18.FlamandCet al.Impact of" exact="Zika" post="virus emergence in French Guiana: a large general-population seroprevalence"/>
 <result pre="general-population seroprevalence surveyJ. Infect. Dis.20192201915192510.1093/infdis/jiz39631418012 19.AubryMet al.Seroprevalence of dengue and" exact="Chikungunya" post="virus antibodies, French Polynesia, 2014-2015Emerg. Infect. Dis.20182455856110.3201/eid2403.17114929460745 20.Van BortelWet"/>
 <result pre="Cruz2018113e17039810.1590/0074-0276017039829538490 23.FritzellCet al.Current challenges and implications for dengue, chikungunya and" exact="Zika" post="seroprevalence studies worldwide: a scoping reviewPLoS Negl. Trop. Dis.201812e000653310.1371/journal.pntd.000653330011271"/>
 <result pre="reviewPLoS Negl. Trop. Dis.201812e000653310.1371/journal.pntd.000653330011271 24.Cao-LormeauVMet al.Guillain-Barre Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 25.CauchemezSet"/>
</results>
